Skip to main content

Asenapin Sinteza References Spoljašnje veze Мени за навигацијуMonografijaa61001565576-45-6WHO163091222300725JKZ19V908OCHEMBL1201756„Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA”„FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)”U.S. Patent 4.145.434Saphris websiteOrganon websiteOrganon Continues With The Development Of Asenapine For Schizophrenia And Acute Mania Associated With Bipolar I Disorderууууу

Атипични антипсихотициМодулатори рецептораОксепиниХлороарениПиролизидини5-ХТ6 антагонисти


atipični antipsihotikšizofrenijebipolar poremećajfazu IIIAkzo Nobelakliničkim ispitivanjimaFDA2009natrijumamonijakuAzaperonBenperidolBromperidolDroperidolFluanizonHaloperidolLenperonMoperonPipamperonSpiperonTimiperonTrifluperidolKlopimozidFluspirilenPenfluridolPimozidAcepromazinAcetofenazinButaperazinKarfenazinHloracizinHlorproetazinHlorpromazinCijamemazinDiksirazinFluacizinFlufenazinLevomepromazin/MetotrimeprazinMezoridazinPerazinPericijazinPerfenazinPiperacetazinPipotiazinProhlorperazinPromazinPrometazinPropiomazinSulforidazinTietilperazinTiopropazatTioproperazinTioridazinTrifluoperazinTriflupromazinHlorprotiksenKlopentiksolFlupentiksolTiotiksenZuklopentiksolButaklamolFluotracenLoksapinTrimipraminCinuperonMelperonSetoperonIloperidonOkaperidonPaliperidonRisperidonLurasidonePerospironRevospironTiospironZiprasidonAmperozidAripiprazolBifeprunoksBrekspiprazolElopiprazolUmespironAmoksapinAsenapinKarpipraminKlocapraminKlorotepinKlotiapinKlozapinFluperlapinGevotrolinMetitepinMosapraminNDMCOlanzapinPihindonKvetijapinTenilapinZotepinWHO-EMPovučeniKlinička ispitivanjaFaza IIINije dospeo do faze IIIMPSOPSImeprdsrdodbpasspecspvoprocN5A5B5C6A6B6DAkrivastinAlinastinAstemizolAzelastinBamirastinBarmastinBepiastinBepotastinBilastinKabastinenKarebastinKetirizinKlemastinKlemizolKlobenztropinDorastinEbastinEmedastinEpinastinFlezelastinKetotifenLatrepirdinLevokabastinLinetastinLoratadinMapinastinMebhidrolinMizolastinMoksastinNoberastinOktastinOlopatadinPerastinPiklopastinRokastinRupatadinSetastinTalastinTemelastinTerfenadinZepastinDesloratadinFeksofenadinCetirizin‎‎LevocetirizinBelarizinEfletirizinElbanizinFlotrenizinMedrilaminNapaktadinPibaksizinTagorizinTrelnarizinTrenizinVapitadin










(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="https://meta.wikimedia.org/wiki/%D0%92%D0%B5%D0%BB%D0%B8%D0%BA%D0%BE_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%BD%D0%BE_%D1%81%D1%80%D0%B5%D1%92%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%9E%D1%81%D1%82%D0%B0%D0%B2%D0%B5" class="extiw" title="meta:Велико пролећно сређивање Оставе"u003Eu003Cspan style="color:white"u003EУчествуј у Великом пролећном сређивању Оставе од 15. марта до 15. априла!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eu003Cspan style="color:white"u003EТакмичи се у писању чланака о средњој и источној Европи од 21. марта до 31. маја!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.2em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је расправа о u003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%9F%D1%80%D0%B0%D0%B2%D0%BE_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%BE%D1%80_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D1%84%D0%B5%D1%98%D1%81%D0%B0" title="Википедија:Гласање/Предлог/Право администратор интерфејса"u003Eu003Cspan style="color:white"u003Eадминистраторима интерфејсаu003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.2em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је гласање о u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D0%BE%D0%B2%D0%B5%D1%9B%D0%B0%D1%9A%D0%B5_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%B7%D0%B0_%D1%81%D0%BB%D0%B8%D0%BA%D0%B5_%D0%BD%D0%B0_%D0%B3%D0%BB%D0%B0%D0%B2%D0%BD%D0%BE%D1%98_%D1%81%D1%82%D1%80%D0%B0%D0%BD%D0%B8" title="Википедија:Гласање/Повећање простора за слике на главној страни"u003Eu003Cspan style="color:white"u003Eповећању простора за слике на главној страниu003C/spanu003Eu003C/au003E и u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B0%D0%B2%D0%B8%D0%BB%D0%B0_%D0%B7%D0%B0_%D0%BA%D0%BE%D1%80%D0%B8%D1%88%D1%9B%D0%B5%D1%9A%D0%B5_%D0%B8%D0%BC%D0%B5%D0%BD%D1%81%D0%BA%D0%BE%D0%B3_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%9D%D0%B0%D1%86%D1%80%D1%82" title="Википедија:Гласање/Правила за коришћење именског простора Нацрт"u003Eu003Cspan style="color:white"u003Eкоришћењу именског простора Нацртu003C/spanu003Eu003C/au003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());




Asenapin




Из Википедије, слободне енциклопедије






Иди на навигацију
Иди на претрагу








































Asenapin (Safris, Sikrest) je atipični antipsihotik koji je razvijen za tretman šizofrenije i akutne manije vezane za bipolar poremećaj. Lek je ušao u fazu III kliničkih ispitivanja do je Organon još bio deo Akzo Nobela.[1] Preliminarni podaci indiciraju da asenapin proizvodi minimalne antiholinergičke i kardiovaskularne nuspojave, kao i minimalno uvećanje telesne težine. Preko 3000 pacijenata je učestvovalo u kliničkim ispitivanjima, i FDA je odobrila lek 2009.[2][3]



Sinteza


Jedan od mogućih sintetičkih puteva je[4]


Asenapine scheme.png

U reducionom koraku se koristi natrijum u tečnom amonijaku.



References




  1. ^ „Bipolar Disorder”. Clinical Trials Update. Genetic Engineering & Biotechnology News. 15. 6. 2007. стр. 52,55.  |access-date= захтева |url= (помоћ)


  2. ^ „Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA” (Саопштење). Schering-Plough. 26. 11. 2007. Приступљено 29. 12. 2008. 


  3. ^ „FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)”. 


  4. ^ J. van der Burg, U.S. Patent 4.145.434.



Spoljašnje veze



  • Saphris website

  • Organon website

  • Organon Continues With The Development Of Asenapine For Schizophrenia And Acute Mania Associated With Bipolar I Disorder


Asenapin
Skeletal formula
Ball-and-stick model

IUPAC ime
(3aRS,12bRS)-rel-5-hloro-2,3,3a,12b-tetrahidro-
2-metil-1H-dibenz[2,3:6,7]oksepino[4,5-c]pirol
Klinički podaci
Drugs.comMonografija
MedlinePlusa610015
Kategorija trudnoće


  • US: C (Mogući rizik)

Način primenesablingualno
Pravni status
Pravni status

  • ℞ (Prescription only)


Farmakokinetički podaci
Bioraspoloživost35% sablingualno
Vezivanje proteina95%
Metabolizamhepatički
Poluvreme eliminacije24 sata
Izlučivanje50% urin, 40% izmet

Identifikatori
CAS broj
65576-45-6 ДаY
ATC kod
N05AH05 (WHO)
PubChemCID 163091
IUPHAR/BPS22
ChemSpider
2300725 ДаY
UNII
JKZ19V908O ДаY
ChEMBL
CHEMBL1201756 ДаY
Hemijski podaci
Formula
C17H16ClNO
Molarna masa285,77 g/mol










Star of life.svgMolimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).








Преузето из „https://sr.wikipedia.org/w/index.php?title=Asenapin&oldid=12037540”










Мени за навигацију


























(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"1.224","walltime":"1.437","ppvisitednodes":"value":7089,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":794568,"limit":2097152,"templateargumentsize":"value":87692,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":3505,"limit":5000000,"entityaccesscount":"value":0,"limit":400,"timingprofile":["100.00% 803.026 1 -total"," 40.56% 325.701 1 Шаблон:Drugbox-lat"," 39.09% 313.872 3 Шаблон:Infobox"," 25.11% 201.668 3 Шаблон:Navbox_with_collapsible_sections"," 16.17% 129.840 1 Шаблон:Reflist"," 15.26% 122.582 26 Шаблон:Navbox_subgroup"," 10.96% 88.005 1 Шаблон:Dopaminergici-lat"," 9.43% 75.735 1 Шаблон:Adrenergici-lat"," 9.30% 74.668 1 Шаблон:Cite_news"," 8.14% 65.368 3 Шаблон:Navbox"],"scribunto":"limitreport-timeusage":"value":"0.284","limit":"10.000","limitreport-memusage":"value":5376471,"limit":52428800,"cachereport":"origin":"mw1323","timestamp":"20190403194659","ttl":2592000,"transientcontent":false);mw.config.set("wgBackendResponseTime":181,"wgHostname":"mw1246"););

Popular posts from this blog

19. јануар Садржај Догађаји Рођења Смрти Празници и дани сећања Види још Референце Мени за навигацијуу

Israel Cuprins Etimologie | Istorie | Geografie | Politică | Demografie | Educație | Economie | Cultură | Note explicative | Note bibliografice | Bibliografie | Legături externe | Meniu de navigaresite web oficialfacebooktweeterGoogle+Instagramcanal YouTubeInstagramtextmodificaremodificarewww.technion.ac.ilnew.huji.ac.ilwww.weizmann.ac.ilwww1.biu.ac.ilenglish.tau.ac.ilwww.haifa.ac.ilin.bgu.ac.ilwww.openu.ac.ilwww.ariel.ac.ilCIA FactbookHarta Israelului"Negotiating Jerusalem," Palestine–Israel JournalThe Schizoid Nature of Modern Hebrew: A Slavic Language in Search of a Semitic Past„Arabic in Israel: an official language and a cultural bridge”„Latest Population Statistics for Israel”„Israel Population”„Tables”„Report for Selected Countries and Subjects”Human Development Report 2016: Human Development for Everyone„Distribution of family income - Gini index”The World FactbookJerusalem Law„Israel”„Israel”„Zionist Leaders: David Ben-Gurion 1886–1973”„The status of Jerusalem”„Analysis: Kadima's big plans”„Israel's Hard-Learned Lessons”„The Legacy of Undefined Borders, Tel Aviv Notes No. 40, 5 iunie 2002”„Israel Journal: A Land Without Borders”„Population”„Israel closes decade with population of 7.5 million”Time Series-DataBank„Selected Statistics on Jerusalem Day 2007 (Hebrew)”Golan belongs to Syria, Druze protestGlobal Survey 2006: Middle East Progress Amid Global Gains in FreedomWHO: Life expectancy in Israel among highest in the worldInternational Monetary Fund, World Economic Outlook Database, April 2011: Nominal GDP list of countries. Data for the year 2010.„Israel's accession to the OECD”Popular Opinion„On the Move”Hosea 12:5„Walking the Bible Timeline”„Palestine: History”„Return to Zion”An invention called 'the Jewish people' – Haaretz – Israel NewsoriginalJewish and Non-Jewish Population of Palestine-Israel (1517–2004)ImmigrationJewishvirtuallibrary.orgChapter One: The Heralders of Zionism„The birth of modern Israel: A scrap of paper that changed history”„League of Nations: The Mandate for Palestine, 24 iulie 1922”The Population of Palestine Prior to 1948originalBackground Paper No. 47 (ST/DPI/SER.A/47)History: Foreign DominationTwo Hundred and Seventh Plenary Meeting„Israel (Labor Zionism)”Population, by Religion and Population GroupThe Suez CrisisAdolf EichmannJustice Ministry Reply to Amnesty International Report„The Interregnum”Israel Ministry of Foreign Affairs – The Palestinian National Covenant- July 1968Research on terrorism: trends, achievements & failuresThe Routledge Atlas of the Arab–Israeli conflict: The Complete History of the Struggle and the Efforts to Resolve It"George Habash, Palestinian Terrorism Tactician, Dies at 82."„1973: Arab states attack Israeli forces”Agranat Commission„Has Israel Annexed East Jerusalem?”original„After 4 Years, Intifada Still Smolders”From the End of the Cold War to 2001originalThe Oslo Accords, 1993Israel-PLO Recognition – Exchange of Letters between PM Rabin and Chairman Arafat – Sept 9- 1993Foundation for Middle East PeaceSources of Population Growth: Total Israeli Population and Settler Population, 1991–2003original„Israel marks Rabin assassination”The Wye River Memorandumoriginal„West Bank barrier route disputed, Israeli missile kills 2”"Permanent Ceasefire to Be Based on Creation Of Buffer Zone Free of Armed Personnel Other than UN, Lebanese Forces"„Hezbollah kills 8 soldiers, kidnaps two in offensive on northern border”„Olmert confirms peace talks with Syria”„Battleground Gaza: Israeli ground forces invade the strip”„IDF begins Gaza troop withdrawal, hours after ending 3-week offensive”„THE LAND: Geography and Climate”„Area of districts, sub-districts, natural regions and lakes”„Israel - Geography”„Makhteshim Country”Israel and the Palestinian Territories„Makhtesh Ramon”„The Living Dead Sea”„Temperatures reach record high in Pakistan”„Climate Extremes In Israel”Israel in figures„Deuteronom”„JNF: 240 million trees planted since 1901”„Vegetation of Israel and Neighboring Countries”Environmental Law in Israel„Executive branch”„Israel's election process explained”„The Electoral System in Israel”„Constitution for Israel”„All 120 incoming Knesset members”„Statul ISRAEL”„The Judiciary: The Court System”„Israel's high court unique in region”„Israel and the International Criminal Court: A Legal Battlefield”„Localities and population, by population group, district, sub-district and natural region”„Israel: Districts, Major Cities, Urban Localities & Metropolitan Areas”„Israel-Egypt Relations: Background & Overview of Peace Treaty”„Solana to Haaretz: New Rules of War Needed for Age of Terror”„Israel's Announcement Regarding Settlements”„United Nations Security Council Resolution 497”„Security Council resolution 478 (1980) on the status of Jerusalem”„Arabs will ask U.N. to seek razing of Israeli wall”„Olmert: Willing to trade land for peace”„Mapping Peace between Syria and Israel”„Egypt: Israel must accept the land-for-peace formula”„Israel: Age structure from 2005 to 2015”„Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition”10.1016/S0140-6736(15)61340-X„World Health Statistics 2014”„Life expectancy for Israeli men world's 4th highest”„Family Structure and Well-Being Across Israel's Diverse Population”„Fertility among Jewish and Muslim Women in Israel, by Level of Religiosity, 1979-2009”„Israel leaders in birth rate, but poverty major challenge”„Ethnic Groups”„Israel's population: Over 8.5 million”„Israel - Ethnic groups”„Jews, by country of origin and age”„Minority Communities in Israel: Background & Overview”„Israel”„Language in Israel”„Selected Data from the 2011 Social Survey on Mastery of the Hebrew Language and Usage of Languages”„Religions”„5 facts about Israeli Druze, a unique religious and ethnic group”„Israël”Israel Country Study Guide„Haredi city in Negev – blessing or curse?”„New town Harish harbors hopes of being more than another Pleasantville”„List of localities, in alphabetical order”„Muncitorii români, doriți în Israel”„Prietenia româno-israeliană la nevoie se cunoaște”„The Higher Education System in Israel”„Middle East”„Academic Ranking of World Universities 2016”„Israel”„Israel”„Jewish Nobel Prize Winners”„All Nobel Prizes in Literature”„All Nobel Peace Prizes”„All Prizes in Economic Sciences”„All Nobel Prizes in Chemistry”„List of Fields Medallists”„Sakharov Prize”„Țara care și-a sfidat "destinul" și se bate umăr la umăr cu Silicon Valley”„Apple's R&D center in Israel grew to about 800 employees”„Tim Cook: Apple's Herzliya R&D center second-largest in world”„Lecții de economie de la Israel”„Land use”Israel Investment and Business GuideA Country Study: IsraelCentral Bureau of StatisticsFlorin Diaconu, „Kadima: Flexibilitate și pragmatism, dar nici un compromis în chestiuni vitale", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 71-72Florin Diaconu, „Likud: Dreapta israeliană constant opusă retrocedării teritoriilor cureite prin luptă în 1967", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 73-74MassadaIsraelul a crescut in 50 de ani cât alte state intr-un mileniuIsrael Government PortalIsraelIsraelIsraelmmmmmXX451232cb118646298(data)4027808-634110000 0004 0372 0767n7900328503691455-bb46-37e3-91d2-cb064a35ffcc1003570400564274ge1294033523775214929302638955X146498911146498911

Кастелфранко ди Сопра Становништво Референце Спољашње везе Мени за навигацију43°37′18″ СГШ; 11°33′32″ ИГД / 43.62156° СГШ; 11.55885° ИГД / 43.62156; 11.5588543°37′18″ СГШ; 11°33′32″ ИГД / 43.62156° СГШ; 11.55885° ИГД / 43.62156; 11.558853179688„The GeoNames geographical database”„Istituto Nazionale di Statistica”проширитиууWorldCat156923403n850174324558639-1cb14643287r(подаци)